������ϲ�����

�ѱ�徱�岹�ٲ�’s Rave Grants Manager will be implemented across 50 multinational studies and multiple therapeutic areas

Sydney, 14 November 2023 – ������ϲ�����, a Dassault Systèmes company and leading provider of clinical trial solutions to the life sciences industry, announced that George Clinical, a leading global contract research organization, is leveraging ������ϲ�����'s cloud-based clinical solution, ������ϲ����� Rave Grants Manager. This collaboration aims to revolutionize the operational efficiency of clinical trials by integrating George Clinical's expertise in clinical research with Rave Grants Manager, allowing George Clinical to provide its global clients with a robust, data-driven approach to quickly and accurately develop investigator grant budgets, enhancing operations, and increasing financial oversight.

Rave Grants Manager is a powerful solution designed to streamline and simplify the clinical trial investigator grant financial management process with greater control. Powered by a dynamic database with a multi-dimensional approach to fair market value, Sponsors and Contract Research Organizations (CROs) can efficiently allocate time, funds, and resources while nurturing site relationships through fair and comprehensive management.

“George Clinical’s mission is to improve the health of millions of people worldwide through clinical research supported by global service delivery, world-class scientific leadership, and therapeutic expertise. With Rave Grants Manager, our clients can engage patient populations and reduce sponsor R&D costs, while maintaining the highest scientific integrity,” said Susan Cole, regional head project operations, USA & Europe at George Clinical.

“Currently, 80% of Sponsors’ time and effort in their financial planning is being consumed by manual processes and workarounds. Rave Grants Manager empowers CROs like George Clinical to make smarter decisions with data-powered financial management for clinical trials. By enhancing operational performance, Grants Manager enables sites to spend less time worrying about finances and shift their focus back to the studies and the care of patients,” said Edwin Ng, senior vice president, general manager, Asia Pacific at ������ϲ�����.

About ������ϲ�����
������ϲ����� is powering smarter treatments and healthier people through digital solutions to support clinical trials. With over 20 years of groundbreaking technological innovation across more than 30,000 trials and 9 million patients, ������ϲ����� offers industry-leading expertise, analytics-powered insights, and the largest patient-level historical clinical trial data set in the world. More than 1 million registered users across 2,100+ customers trust �ѱ�徱�岹�ٲ�’s seamless, end-to-end platform to improve patient experiences, accelerate clinical breakthroughs, and bring therapies to market faster. The company is a wholly owned subsidiary of Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA), which with its 3DEXPERIENCE platform is positioned to lead the digital transformation of life sciences in the age of personalized medicine with the first end-to-end scientific and business platform, from research to commercialization. ������ϲ����� is headquartered in New York City and has been recognized as a Leader by Everest Group and IDC. Discover more at www.medidata.com and follow us

About Dassault Systèmes

Dassault Systèmes, the 3DEXPERIENCE® Company, is a catalyst for human progress. We provide business and people with collaborative virtual environments to imagine sustainable innovations. By creating virtual twin experiences of the real world with our 3DEXPERIENCE platform and applications, our customers can redefine the creation, production and life-cycle-management processes of their offer and thus have a meaningful impact to make the world more sustainable. The beauty of the Experience Economy is that it is a human-centered economy for the benefit of all –consumers, patients and citizens. Dassault Systèmes brings value to more than 300,000 customers of all sizes, in all industries, in more than 150 countries. For more information, visit .

^© Dassault Systèmes. All rights reserved. 3DEXPERIENCE, the 3DS logo, the Compass icon, IFWE, 3DEXCITE, 3DVIA, BIOVIA, CATIA, CENTRIC PLM, DELMIA, ENOVIA, GEOVIA, MEDIDATA, NETVIBES, OUTSCALE, SIMULIA and SOLIDWORKS are commercial trademarks or registered trademarks of Dassault Systèmes, a European company (Societas Europaea) incorporated under French law, and registered with the Versailles trade and companies registry under number 322 306 440, or its subsidiaries in the United States and/or other countries.